Results 301 to 310 of about 874,138 (343)

[Intestinal parasitic diseases].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1996
O, Saito, K, Katsu
openaire   +1 more source

Host‐Guest Inclusion Chemistry From Supramolecular Architecture Enabling Anti‐Biofouling Surfaces for Oesophagus Stents

Advanced Functional Materials, EarlyView.
A slippery coating with exceptional anti‐biofouling performance is developed using biocompatible materials for oesophagus stents. Host‐guest inclusion complex formation capabilities of FDA‐approved supramolecules, cyclodextrins are exploited, which significantly enhances the stability of the surface.
Jianhui Zhang, Haowei Wang, Sourabh Dogra, Xiaoye Zhao, Wenqing Chen, Arpan Gupta, Manish K. Tiwari, Vikramjeet Singh   +7 more
wiley   +1 more source

Single Cell Integration Characterises Metaplasia in Inflammatory Intestinal Diseases

Oliver AJ, Huang N, Li R, Bartolome-Casado R, Nilsen HR, Gudino V, Melon-Ardanaz CdIBe, Fitzpatrick MEB, Provine NM, Polanski K, Koplev S, Milchsack LM, Dann E, Predeus AV, Cakir B, To K, Prete M, Chapman JA, Masi AC, Stephenson E, Engelbert J, Lobentanzer S, Perera S, Richardson L, Kapuge R, Wilbrey-Clark A, Semprich CI, Moy M, Ellams S, Tudor CL, Joseph P, Garrido-Trigo A, Corraliza CdIBe, Oliver TR, Hook CE, Saez-Rodriguez J, James KR, Meyer KB, Mahbubani KT, Saeb-Parsy K, Zilbauer M, Hoivik ML, Baekkevold ES, Salas CdIBe, Stewart CJ, Berrington JE, Klenerman P, Haniffa M, Jahnsen FL, Elmentaite R, Teichmann SA.   +50 more
europepmc   +1 more source

Risk factors for anastomotic complications after elective intestinal resection in Crohn’s disease

Ali Emre Atıcı, Ayşegül Bahar Özocak, Gülşah Filiz Karpuz, Halil İbrahim Sevindi, Şerif Furkan Dağancı, Cumhur Yeğen   +5 more
openalex   +1 more source

Faecal sample storage without ethanol for up to 24 h followed by freezing performs better than storage with ethanol for shotgun metagenomic microbiome analysis in patients with inflammatory and non-inflammatory intestinal diseases and healthy controls. [PDF]

BMC Res Notes
Grønbæk IMB, Mollerup S, Halkjær SI, Paulsen SJ, Pinholt M, Westh H, Petersen AM.   +6 more
europepmc   +1 more source

[Inflammatory intestinal diseases].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001
T, Hibi, M, Naganuma
openaire   +1 more source

Inflammatory Intestinal Diseases

, 2016
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Potential Application of Intestinal Organoids in Intestinal Diseases

Stem Cell Reviews and Reports, 2023
To accurately reveal the scenario and mecahnism of gastrointestinal diseases, the establishment of in vitro models of intestinal diseases and drug screening platforms have become the focus of attention. Over the past few decades, animal models and immortalized cell lines have provided valuable but limited insights into gastrointestinal research.
Wenxiu Liu, Qian Wang, Yanrui Bai, Han Xiao, Zhunduo Li, Yan Wang, Qi Wang, Jing Yang, Hui Sun   +8 more
openaire   +2 more sources

Proteolysis in Intestinal Disease

Gastroenterology, 1950
Summary Proteolytic activity in the feces of fifty cases of various types of intestinal disease was investigated. There were normal controls, and also a study of the contents of the small intestine of four patients. Proteolysis of egg albumin, muscle and gastric mucin were tested.
S, WARREN, S C, SOMMERS
openaire   +2 more sources

INTESTINAL LIPODYSTROPHY (WHIPPLE'S DISEASE)

Archives of Surgery, 1951
THE RARE occurrence and infrequent recognition of intestinal lipodystrophy as described by Whipple1in 1907 appears to warrant report of a case diagnosed recently during laparotomy. The case reported by Whipple was characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues.
L T, PALUMBO, G M, RUGTIV
openaire   +2 more sources